{"id":27593,"date":"2023-03-01T09:18:00","date_gmt":"2023-03-01T08:18:00","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=27593"},"modified":"2023-03-17T09:26:51","modified_gmt":"2023-03-17T08:26:51","slug":"un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/","title":{"rendered":"Un programme de formation continue pr\u00e9sent\u00e9 par\u00a0R\u00e9Pias PRIMO\u00a0et\u00a0MATIS, en lien avec l\u2019association FCBM"},"content":{"rendered":"\n<p>Les\u00a0<strong>missions nationales du R\u00e9Pias PRIMO<\/strong>\u00a0et<strong>MATIS<\/strong>, en lien avec l\u2019association FCBM (formation continue de biologie et m\u00e9decine), pr\u00e9sentent\u00a0<a rel=\"noreferrer noopener\" href=\"https:\/\/www.preventioninfection.fr\/e-preventimages\/\" target=\"_blank\">e-PREVENTImAgeS\u00a0<\/a>: un programme de formation continue, exclusivement en ligne, destin\u00e9 aux m\u00e9decins g\u00e9n\u00e9ralistes mais plus largement \u00e0 tous les professionnels de sant\u00e9 souhaitant se perfectionner en pr\u00e9vention des infections et de l\u2019antibior\u00e9sistance. En 2023, une session de 4 dossiers de cas cliniques en m\u00e9decine de\u00a0 ville sera propos\u00e9e entre le 15 mars et le 28 d\u00e9cembre.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les\u00a0missions nationales du R\u00e9Pias PRIMO\u00a0etMATIS, en lien avec l\u2019association FCBM (formation continue de biologie et m\u00e9decine), pr\u00e9sentent\u00a0e-PREVENTImAgeS\u00a0: un programme de formation continue, exclusivement en ligne, destin\u00e9 aux m\u00e9decins g\u00e9n\u00e9ralistes mais plus largement \u00e0 tous les professionnels de sant\u00e9 souhaitant se perfectionner en pr\u00e9vention des infections et de l\u2019antibior\u00e9sistance. En 2023, une session de 4 dossiers [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Un programme de formation continue pr\u00e9sent\u00e9 par\u00a0R\u00e9Pias PRIMO\u00a0et\u00a0MATIS, en lien avec l\u2019association FCBM - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un programme de formation continue pr\u00e9sent\u00e9 par\u00a0R\u00e9Pias PRIMO\u00a0et\u00a0MATIS, en lien avec l\u2019association FCBM - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-01T08:18:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-17T08:26:51+00:00\" \/>\n<meta name=\"author\" content=\"Emmanuel Auchet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emmanuel Auchet\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/\"},\"author\":{\"name\":\"Emmanuel Auchet\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8\"},\"headline\":\"Un programme de formation continue pr\u00e9sent\u00e9 par\u00a0R\u00e9Pias PRIMO\u00a0et\u00a0MATIS, en lien avec l\u2019association FCBM\",\"datePublished\":\"2023-03-01T08:18:00+00:00\",\"dateModified\":\"2023-03-17T08:26:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/\"},\"wordCount\":102,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/\",\"name\":\"Un programme de formation continue pr\u00e9sent\u00e9 par\u00a0R\u00e9Pias PRIMO\u00a0et\u00a0MATIS, en lien avec l\u2019association FCBM - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"datePublished\":\"2023-03-01T08:18:00+00:00\",\"dateModified\":\"2023-03-17T08:26:51+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Un programme de formation continue pr\u00e9sent\u00e9 par\u00a0R\u00e9Pias PRIMO\u00a0et\u00a0MATIS, en lien avec l\u2019association FCBM\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8\",\"name\":\"Emmanuel Auchet\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un programme de formation continue pr\u00e9sent\u00e9 par\u00a0R\u00e9Pias PRIMO\u00a0et\u00a0MATIS, en lien avec l\u2019association FCBM - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/","og_locale":"fr_FR","og_type":"article","og_title":"Un programme de formation continue pr\u00e9sent\u00e9 par\u00a0R\u00e9Pias PRIMO\u00a0et\u00a0MATIS, en lien avec l\u2019association FCBM - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2023-03-01T08:18:00+00:00","article_modified_time":"2023-03-17T08:26:51+00:00","author":"Emmanuel Auchet","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Emmanuel Auchet"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/"},"author":{"name":"Emmanuel Auchet","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8"},"headline":"Un programme de formation continue pr\u00e9sent\u00e9 par\u00a0R\u00e9Pias PRIMO\u00a0et\u00a0MATIS, en lien avec l\u2019association FCBM","datePublished":"2023-03-01T08:18:00+00:00","dateModified":"2023-03-17T08:26:51+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/"},"wordCount":102,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/","name":"Un programme de formation continue pr\u00e9sent\u00e9 par\u00a0R\u00e9Pias PRIMO\u00a0et\u00a0MATIS, en lien avec l\u2019association FCBM - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"datePublished":"2023-03-01T08:18:00+00:00","dateModified":"2023-03-17T08:26:51+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/un-programme-de-formation-continue-presente-par-repias-primo-et-matis-en-lien-avec-lassociation-fcbm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"Un programme de formation continue pr\u00e9sent\u00e9 par\u00a0R\u00e9Pias PRIMO\u00a0et\u00a0MATIS, en lien avec l\u2019association FCBM"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8","name":"Emmanuel Auchet"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-16 16:58:29","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/27593"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=27593"}],"version-history":[{"count":3,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/27593\/revisions"}],"predecessor-version":[{"id":27619,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/27593\/revisions\/27619"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=27593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=27593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=27593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}